Logo image of MDRR

MEDALIST DIVERSIFIED REIT IN (MDRR) Stock Fundamental Analysis

USA - NASDAQ:MDRR - US58403P4028 - REIT

13.5 USD
0 (0%)
Last: 10/13/2025, 12:15:41 PM
Fundamental Rating

2

MDRR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. Both the profitability and financial health of MDRR have multiple concerns. MDRR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MDRR has reported negative net income.
MDRR had a positive operating cash flow in the past year.
MDRR had negative earnings in 4 of the past 5 years.
Of the past 5 years MDRR 4 years had a positive operating cash flow.
MDRR Yearly Net Income VS EBIT VS OCF VS FCFMDRR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -2.92%, MDRR is not doing good in the industry: 75.97% of the companies in the same industry are doing better.
MDRR's Return On Equity of -16.94% is on the low side compared to the rest of the industry. MDRR is outperformed by 81.40% of its industry peers.
MDRR's Return On Invested Capital of 0.61% is on the low side compared to the rest of the industry. MDRR is outperformed by 86.05% of its industry peers.
Industry RankSector Rank
ROA -2.92%
ROE -16.94%
ROIC 0.61%
ROA(3y)-3.64%
ROA(5y)-5.19%
ROE(3y)-21.52%
ROE(5y)-32.04%
ROIC(3y)N/A
ROIC(5y)N/A
MDRR Yearly ROA, ROE, ROICMDRR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Operating Margin of MDRR (6.14%) is worse than 82.95% of its industry peers.
MDRR's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 74.80%, MDRR is in the better half of the industry, outperforming 71.32% of the companies in the same industry.
In the last couple of years the Gross Margin of MDRR has grown nicely.
Industry RankSector Rank
OM 6.14%
PM (TTM) N/A
GM 74.8%
OM growth 3Y19.99%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.15%
GM growth 5Y9.83%
MDRR Yearly Profit, Operating, Gross MarginsMDRR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MDRR is destroying value.
The number of shares outstanding for MDRR has been increased compared to 1 year ago.
Compared to 5 years ago, MDRR has more shares outstanding
Compared to 1 year ago, MDRR has an improved debt to assets ratio.
MDRR Yearly Shares OutstandingMDRR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
MDRR Yearly Total Debt VS Total AssetsMDRR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

MDRR has an Altman-Z score of -0.35. This is a bad value and indicates that MDRR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.35, MDRR is not doing good in the industry: 81.40% of the companies in the same industry are doing better.
A Debt/Equity ratio of 3.24 is on the high side and indicates that MDRR has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 3.24, MDRR is doing worse than 82.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Altman-Z -0.35
ROIC/WACC0.1
WACC6.4%
MDRR Yearly LT Debt VS Equity VS FCFMDRR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

MDRR has a Current Ratio of 1.52. This is a normal value and indicates that MDRR is financially healthy and should not expect problems in meeting its short term obligations.
MDRR's Current ratio of 1.52 is fine compared to the rest of the industry. MDRR outperforms 66.67% of its industry peers.
MDRR has a Quick Ratio of 1.52. This is a normal value and indicates that MDRR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MDRR (1.52) is better than 67.44% of its industry peers.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
MDRR Yearly Current Assets VS Current LiabilitesMDRR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M

1

3. Growth

3.1 Past

The earnings per share for MDRR have decreased strongly by -194.32% in the last year.
MDRR shows a decrease in Revenue. In the last year, the revenue decreased by -5.12%.
Measured over the past years, MDRR shows a small growth in Revenue. The Revenue has been growing by 3.29% on average per year.
EPS 1Y (TTM)-194.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.7%
Revenue 1Y (TTM)-5.12%
Revenue growth 3Y-5.32%
Revenue growth 5Y3.29%
Sales Q2Q%7.34%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MDRR Yearly Revenue VS EstimatesMDRR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
MDRR Yearly EPS VS EstimatesMDRR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 -5 -10 -15

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MDRR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MDRR Price Earnings VS Forward Price EarningsMDRR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

MDRR's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.59
MDRR Per share dataMDRR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

MDRR has a Yearly Dividend Yield of 2.00%.
Compared to an average industry Dividend Yield of 7.01, MDRR's dividend is way lower than its industry peers. On top of this 86.82% of the companies listed in the same industry pay a better dividend than MDRR!
MDRR's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2%

5.2 History

The dividend of MDRR decreases each year by -35.49%.
MDRR has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-35.49%
Div Incr Years0
Div Non Decr Years0
MDRR Yearly Dividends per shareMDRR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5.3 Sustainability

The earnings of MDRR are negative and hence is the payout ratio. MDRR will probably not be able to sustain this dividend level.
DP-20.23%
EPS Next 2YN/A
EPS Next 3YN/A
MDRR Yearly Income VS Free CF VS DividendMDRR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

MEDALIST DIVERSIFIED REIT IN

NASDAQ:MDRR (10/13/2025, 12:15:41 PM)

13.5

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners9.13%
Inst Owner Change0%
Ins Owners39.17%
Ins Owner Change-5.08%
Market Cap18.23M
Analysts82.86
Price TargetN/A
Short Float %1.99%
Short Ratio4.38
Dividend
Industry RankSector Rank
Dividend Yield 2%
Yearly Dividend0.64
Dividend Growth(5Y)-35.49%
DP-20.23%
Div Incr Years0
Div Non Decr Years0
Ex-Date10-09 2025-10-09 (0.0675)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.89
P/FCF N/A
P/OCF 14.83
P/B 1.36
P/tB 1.59
EV/EBITDA 13.59
EPS(TTM)-1.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.91
OCFY6.74%
SpS7.15
BVpS9.93
TBVpS8.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.92%
ROE -16.94%
ROCE 0.78%
ROIC 0.61%
ROICexc 0.63%
ROICexgc 0.66%
OM 6.14%
PM (TTM) N/A
GM 74.8%
FCFM N/A
ROA(3y)-3.64%
ROA(5y)-5.19%
ROE(3y)-21.52%
ROE(5y)-32.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y22.3%
ROICexcg growth 5YN/A
ROICexc growth 3Y22.59%
ROICexc growth 5YN/A
OM growth 3Y19.99%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.15%
GM growth 5Y9.83%
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Debt/EBITDA 9.89
Cap/Depr 32.84%
Cap/Sales 12.96%
Interest Coverage 0.24
Cash Conversion 27.93%
Profit Quality N/A
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z -0.35
F-Score3
WACC6.4%
ROIC/WACC0.1
Cap/Depr(3y)99.7%
Cap/Depr(5y)183.19%
Cap/Sales(3y)42.36%
Cap/Sales(5y)63.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-194.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.7%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.12%
Revenue growth 3Y-5.32%
Revenue growth 5Y3.29%
Sales Q2Q%7.34%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-55.72%
EBIT growth 3Y13.61%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y97.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y156.06%
OCF growth 3Y29.35%
OCF growth 5Y17.27%